Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures
NEW JERSEY and HANGZHOU, CHINA, Jul 15, 2021 – (ACN Newswire via SEAPRWire.com) – Adlai Nortye Ltd. (hereinafter referred to as “Adlai Nortye”), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing... » read more